Nuvectis Pharma Inc stock is traded at $17.76, with a volume of 340,927. It is down -3.84% in the last 24 hours and down -16.97% over the past month. Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Previous Close:
$18.47
Open:
$18.15
24h Volume:
340,927
Relative Volume:
1.61
Market Cap:
$610.75M
Revenue:
-
Net Income/Loss:
-$29.59M
P/E Ratio:
-
EPS:
-$1.28
Net Cash Flow:
-$18.35M
1W Performance:
-4.36%
1M Performance:
-16.97%
6M Performance:
+82.90%
1Y Performance:
+214.34%
1-Day Range:
$17.24$18.53
1-Week Range:
$17.10$20.55
52-Week Range:
$5.55$29.28
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Name
Nuvectis Pharma IncSector
HealthcareIndustry
BiotechnologyPhone
360-837-7232Address
1 BRIDGE PLAZA, SUITE 275, FORT LEE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS